期刊文献+

3.0T MRI与64排CT评价原发性肝癌介入治疗后疗效的价值 被引量:25

Value of 3.0T MRI and 64-slice CT in Evaluating the Efficacy After Interventional Therapy of Primary Liver Cancer
下载PDF
导出
摘要 目的探讨磁共振成像(MRI)与电子计算机断层扫描(CT)评价原发性肝癌介入治疗后疗效的价值。方法回顾性分析2015年3月-2017年1月间收治的48例原发性肝癌(PLC)患者临床资料,患者均经导管肝动脉化疗栓塞术(TACE)治疗。患者术后复查时均经3.0TMRI、64排CT及数字减影血管造影(DSA)检查,以DSA为标准,比较MRI和CT检查发现残留病灶、复发病灶和病灶包膜的价值。结果 (1)MRI检查残留、复发病灶灵敏度、准确率均高于CT检查(P<0.05);(2)MRI检出Ⅱ型碘油沉积残留、复发病灶率高于CT(P<0.05);Ⅰ型、Ⅲ型、Ⅳ型对比,差异无统计学意义(P>0.05);(3)MRI病灶包膜检出率高于CT(P<0.05)。结论 3.0TMRI更有利于检出原发性肝癌经TACE后残留、复发病灶,受碘油影响较CT小,MRI检出包膜能力也高于CT,在评估PLC经TACE治疗后疗效价值更高。 Objective To explore the value of magnetic resonance imaging(MRI)and computed tomography(CT)in the evaluation of efficacy after interventional therapy of primary liver cancer.Methods The clinical data of 48 patients with primary liver cancer(PLC)admitted to our hospital during March 2015 to January 2017 were analyzed retrospectively.All patients were given transcatheter arterial chemoembolization(TACE),and they were given 3.0 TMRI,64-slice CT and digital subtraction angiography(DSA)examination postoperative review.DSA was used as the standard to compare the value of residual lesions,recurrent lesions and lesion capsule by MRI and CT.Results The sensitivity and accuracy of residual and recurrent lesions by MRI examination were higher than those by CT examination(P<0.05).The detection rates of residual and recurrent lesions of type II lipiodol deposition by MRI were higher than those by CT(P<0.05).There was no significant difference in type I,type III and type IV(P >0.05).The detection rate of capsule by MRI was higher than that by CT(P<0.05).Conclusion 3.0T MRI is more conducive to the detection of residual and recurrent lesions after TACE in PLC,and the effect of iodized oil to the lesion is smaller than that of CT.MRI also has higher ability of capsule detection rate than CT,and it has higher value in evaluating the efficacy after TACE in PLC.
作者 郑新闻 刘丹 李振平 王常富 董志辉 ZHENG Xin-wen;LIU Dan;LI Zhen-ping(Department of Peripheral Intervention,Sanmenxia Central Hospital,Sanmenxia 472000,Henan Province,China)
出处 《中国CT和MRI杂志》 2019年第2期32-34,56,共4页 Chinese Journal of CT and MRI
关键词 原发性肝癌 导管肝动脉化疗栓塞术 磁共振成像 电子计算机断层扫描 Primary Liver Cancer Transcatheter Arterial Chemoembolization Magnetic Resonance Imaging Computed Tomography
  • 相关文献

参考文献14

二级参考文献158

  • 1Shi, Ming,Chen, Ji-An,Lin, Xiao-Jun,Guo, Rong-Ping,Yuan, Yun-Fei,Chen, Min-Shan,Zhang, Ya-Qi,Li, Jin-Qing.Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China[J].World Journal of Gastroenterology,2010,16(2):264-269. 被引量:37
  • 2邱国钦,刘昌华,陈玉强,曾英琅.320排CT血管成像在肝癌介入治疗中的应用[J].实用癌症杂志,2014,29(1):33-36. 被引量:8
  • 3智慧,罗葆明,文艳玲,杨海云,欧冰,马健鸿.无水酒精注射与射频及射频综合治疗体积不等肝癌的疗效比较[J].实用全科医学,2007,5(9):760-761. 被引量:11
  • 4Ross C J, Rennert J, Schacherer D, et al. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-in- terventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatoeellular carcinomas ( HCC ) : preliminary results [ J]. Clinical hemorheology and microcirculation ,2010,46 (2) :101- 115.
  • 5汤雨,周晓东.超声介入治疗原发性肝癌的研究进展[J].第四军医大学学报,2008,29(1):89-92. 被引量:7
  • 6Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol,2008,48 (1): 20-37.
  • 7Bruix J, Sherman M. Practice guidelines committee,American assocition for the hepatocellular carcinama.Hepatolopy,2005,42 (5):1208-1236.
  • 8Llovet JM,Real MI,Montana X,et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unreseetable hepatoeellular careinoma:a randomized controlled trial .Lancet, 2002,359 ( 9319 ): 1734-1739.
  • 9Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular proves survival .Hepatology,2003,37(2):429-442.
  • 10Cosgrove DP,Reyes DK,Pawllk TM,et al. Open-lablel sin- gle-arm phase ]] trial of sorafenib therapy with drug-eluting bead transarterial chemoembolization in patients with unre- sectable hepatocellular carcinoma:clinical results.Radiology, 2015,6( 11 ):142-148.

共引文献868

同被引文献189

引证文献25

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部